Product/Service
CHOZN® ZFN-Modified CHO Cell Lines For Bioproduction
Source: SAFC
The foundation for biopharmaceutical companies to develop a platform production process, thus enabling regulatory acceptance and commercial consistency, is a robust cell line that maintains favorable growth and productivity characteristics.
Click Here To Download:
•Product Sheet: CHOZN® ZFN-Modified CHO Cell Lines For Bioproduction
•Technical Bulletin: CHOZN® ZFN-Modified DHFR-/- CHO Cell Line
•Product Sheet: CHOZN® ZFN-Modified CHO Cell Lines For Bioproduction
•Technical Bulletin: CHOZN® ZFN-Modified DHFR-/- CHO Cell Line
The foundation for biopharmaceutical companies to develop a platform production process, thus enabling regulatory acceptance and commercial consistency, is a robust cell line that maintains favorable growth and productivity characteristics. SAFC® has created a series of zinc finger nuclease (ZFN) modified CHO cell lines with characteristics that are attractive in a platform cell line to biopharmaceutical developers and manufacturers. These characteristics include selecting the cells for their capacity to exhibit:
- Cloning robustness with low or no selection required
- High growth and productivity – both Qp and volumetric
- Suspension growth in chemically-defined media
- Responsiveness to feeds
- Scalability in bioreactors
- Complete traceability and safety testing
Need More Information? Just Ask.
Click the button below to directly contact the supplier. Use it to:
- Ask a question.
- Request more detailed information or literature.
- Discuss your current project/application.
- Request a quote.
- Locate a distributor in your area.
- Schedule a demo.
